Logo image of WULF

TERAWULF INC (WULF) Stock Fundamental Analysis

NASDAQ:WULF - Nasdaq - US88080T1043 - Common Stock - Currency: USD

3.92  -0.08 (-2%)

After market: 3.9297 +0.01 (+0.25%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to WULF. WULF was compared to 283 industry peers in the Software industry. WULF may be in some trouble as it scores bad on both profitability and health. WULF is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

WULF had negative earnings in the past year.
In the past year WULF had a positive cash flow from operations.
WULF had negative earnings in each of the past 5 years.
In the past 5 years WULF reported 4 times negative operating cash flow.
WULF Yearly Net Income VS EBIT VS OCF VS FCFWULF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M -200M -250M

1.2 Ratios

With a Return On Assets value of -14.73%, WULF is not doing good in the industry: 66.08% of the companies in the same industry are doing better.
WULF has a worse Return On Equity (-72.74%) than 74.56% of its industry peers.
Industry RankSector Rank
ROA -14.73%
ROE -72.74%
ROIC N/A
ROA(3y)-19.15%
ROA(5y)-19.16%
ROE(3y)-46.79%
ROE(5y)-44.08%
ROIC(3y)N/A
ROIC(5y)N/A
WULF Yearly ROA, ROE, ROICWULF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

With a Gross Margin value of 44.89%, WULF is not doing good in the industry: 70.32% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of WULF has grown nicely.
The Profit Margin and Operating Margin are not available for WULF so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.89%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y12.53%
WULF Yearly Profit, Operating, Gross MarginsWULF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

More info and screens

1

2. Health

2.1 Basic Checks

WULF does not have a ROIC to compare to the WACC, probably because it is not profitable.
WULF has more shares outstanding than it did 1 year ago.
WULF has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, WULF has a worse debt to assets ratio.
WULF Yearly Shares OutstandingWULF Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
WULF Yearly Total Debt VS Total AssetsWULF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

WULF has an Altman-Z score of 0.58. This is a bad value and indicates that WULF is not financially healthy and even has some risk of bankruptcy.
WULF's Altman-Z score of 0.58 is on the low side compared to the rest of the industry. WULF is outperformed by 67.14% of its industry peers.
A Debt/Equity ratio of 2.87 is on the high side and indicates that WULF has dependencies on debt financing.
WULF has a worse Debt to Equity ratio (2.87) than 80.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.87
Debt/FCF N/A
Altman-Z 0.58
ROIC/WACCN/A
WACC10.25%
WULF Yearly LT Debt VS Equity VS FCFWULF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

WULF has a Current Ratio of 1.90. This is a normal value and indicates that WULF is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.90, WULF is in line with its industry, outperforming 58.30% of the companies in the same industry.
WULF has a Quick Ratio of 1.90. This is a normal value and indicates that WULF is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.90, WULF perfoms like the industry average, outperforming 59.36% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.9
Quick Ratio 1.9
WULF Yearly Current Assets VS Current LiabilitesWULF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

7

3. Growth

3.1 Past

The earnings per share for WULF have decreased strongly by -50.00% in the last year.
The Revenue has grown by 31.85% in the past year. This is a very strong growth!
Measured over the past years, WULF shows a very strong growth in Revenue. The Revenue has been growing by 51.38% on average per year.
EPS 1Y (TTM)-50%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-700%
Revenue 1Y (TTM)31.85%
Revenue growth 3YN/A
Revenue growth 5Y51.38%
Sales Q2Q%-18.92%

3.2 Future

WULF is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 46.16% yearly.
WULF is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 38.04% yearly.
EPS Next Y-20.41%
EPS Next 2Y42.93%
EPS Next 3Y69.84%
EPS Next 5Y46.16%
Revenue Next Year47%
Revenue Next 2Y67.86%
Revenue Next 3Y56.75%
Revenue Next 5Y38.04%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
WULF Yearly Revenue VS EstimatesWULF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M 800M
WULF Yearly EPS VS EstimatesWULF Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.5 -0.5 1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

WULF reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 480.39, the valuation of WULF can be described as expensive.
Based on the Price/Forward Earnings ratio, WULF is valued a bit more expensive than the industry average as 63.60% of the companies are valued more cheaply.
WULF's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.43.
Industry RankSector Rank
PE N/A
Fwd PE 480.39
WULF Price Earnings VS Forward Price EarningsWULF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200 300 400

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WULF Per share dataWULF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 -0.6

4.3 Compensation for Growth

A more expensive valuation may be justified as WULF's earnings are expected to grow with 69.84% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.93%
EPS Next 3Y69.84%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for WULF!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TERAWULF INC

NASDAQ:WULF (5/20/2025, 8:00:02 PM)

After market: 3.9297 +0.01 (+0.25%)

3.92

-0.08 (-2%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-09 2025-05-09/bmo
Earnings (Next)08-11 2025-08-11/bmo
Inst Owners50.3%
Inst Owner Change5.02%
Ins Owners7.51%
Ins Owner Change2.35%
Market Cap1.50B
Analysts81.25
Price Target7.24 (84.69%)
Short Float %33.71%
Short Ratio2.7
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-131.18%
Min EPS beat(2)-133.63%
Max EPS beat(2)-128.73%
EPS beat(4)0
Avg EPS beat(4)-110.63%
Min EPS beat(4)-133.63%
Max EPS beat(4)-63.4%
EPS beat(8)0
Avg EPS beat(8)-105.17%
EPS beat(12)1
Avg EPS beat(12)-117.89%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-15.36%
Min Revenue beat(2)-21.8%
Max Revenue beat(2)-8.92%
Revenue beat(4)0
Avg Revenue beat(4)-13.73%
Min Revenue beat(4)-22.6%
Max Revenue beat(4)-1.59%
Revenue beat(8)0
Avg Revenue beat(8)-12.23%
Revenue beat(12)1
Avg Revenue beat(12)-25.53%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-16.96%
PT rev (3m)-27.8%
EPS NQ rev (1m)-38.89%
EPS NQ rev (3m)-449.89%
EPS NY rev (1m)-53.62%
EPS NY rev (3m)-376.05%
Revenue NQ rev (1m)-12.46%
Revenue NQ rev (3m)-31%
Revenue NY rev (1m)-13.3%
Revenue NY rev (3m)-29.09%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 480.39
P/S 11.39
P/FCF N/A
P/OCF 163.12
P/B 8.83
P/tB 8.83
EV/EBITDA N/A
EPS(TTM)-0.33
EYN/A
EPS(NY)0.01
Fwd EY0.21%
FCF(TTM)-0.8
FCFYN/A
OCF(TTM)0.02
OCFY0.61%
SpS0.34
BVpS0.44
TBVpS0.44
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.73%
ROE -72.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.89%
FCFM N/A
ROA(3y)-19.15%
ROA(5y)-19.16%
ROE(3y)-46.79%
ROE(5y)-44.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y12.53%
F-Score4
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 2.87
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 504.63%
Cap/Sales 238.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.9
Quick Ratio 1.9
Altman-Z 0.58
F-Score4
WACC10.25%
ROIC/WACCN/A
Cap/Depr(3y)536.8%
Cap/Depr(5y)N/A
Cap/Sales(3y)235.52%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-50%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-700%
EPS Next Y-20.41%
EPS Next 2Y42.93%
EPS Next 3Y69.84%
EPS Next 5Y46.16%
Revenue 1Y (TTM)31.85%
Revenue growth 3YN/A
Revenue growth 5Y51.38%
Sales Q2Q%-18.92%
Revenue Next Year47%
Revenue Next 2Y67.86%
Revenue Next 3Y56.75%
Revenue Next 5Y38.04%
EBIT growth 1Y-407.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year348.94%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-330.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y143.34%
OCF growth 3YN/A
OCF growth 5YN/A